4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-22-022857
Sr. VP & General Counsel acquired 21,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gardiner Nathaniel S. Sr. VP & General Counsel | 2022-11-23 | Grant or award | +21,000 | 60,106 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gardiner Nathaniel S. Sr. VP & General Counsel | 2022-11-23 | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | D: show line 2 in the form |
Loading xslF345X03/form4.xml…